THE STATE OF UROLOGIC CANCER CARE IN MOSCOW
https://doi.org/10.17650/1726-9776-2013-9-4-10-13
Abstract
In 2003 malignant neoplasms (MN) of the urinary system and male genital organs affected more than 43,000 people in Russia, amounting to 9.4% in the structure of total cancer morbidity. In 2012, the incidence of urologic cancers at only three sites (prostate, kidney, and bladder) was 12.1%. In the same year, Moscow showed the proportion of patients with new-onset urologic cancer, which accounted for one sixth (16.5%) of the total MN morbidity and almost one fifth (18.5%) of the total number of registered cancer patients.
Supporting agencies: malignant neoplasms; oncology; urology; statistics; cancer register
About the Authors
V. I. Shirokorad
Moscow City Cancer Hospital Sixty-Two
Russian Federation
Russian Federation
A. N. Makhson
Moscow City Cancer Hospital Sixty-Two
Russian Federation
Russian Federation
O. A. Yadykov
Moscow City Cancer Hospital Sixty-Two
Russian Federation
Russian Federation
References
1. Лопаткин Н.А. Онкология и урология – связь между специальностями. Материалы I конгресса Российского общества онкоурологов. Москва, 2006. С. 13.
2. Матвеев Б.П. Приветственное обращение. Онкоурология, 2005;1:5.
3. Состояние онкологической помощи населению России в 2012 году. Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: ФГБУ «МНИОИ им. П.А. Герцена». М., 2013. С. 4, 128, 132, 136.
Review
For citations:
Shirokorad V.I., Makhson A.N., Yadykov O.A. THE STATE OF UROLOGIC CANCER CARE IN MOSCOW. Cancer Urology. 2013;9(4):10-13. (In Russ.) https://doi.org/10.17650/1726-9776-2013-9-4-10-13
Views:
744
Email this article 